B
BRAVEHEART BIO, INC. COMMON STOCK
NASDAQ: BRVE (Braveheart Bio, Inc.)
最近更新时间: 14分钟之前27.36
-0.06 (-0.22%)
AIStockmoo 评分
0.4
| 分析师共识 | 0.0 |
| 内部交易活动 | 3.0 |
| 价格波动 | -1.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.0 |
| 平均 | 0.40 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| AH BIO FUND IV, L.P. | 30.00 | - | 10,232,420 | 306,972,600 |
| ANDERSON MICHELE A. | 30.00 | - | 1,111 | 33,330 |
| CHIMOVITS EREZ | 30.00 | - | 11,072,420 | 332,172,600 |
| FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF U.A. | 30.00 | - | 20,723,287 | 621,698,610 |
| JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. | 30.00 | - | 7,420,091 | 222,602,730 |
| LUBNER DAVID CHARLES | 30.00 | - | 55,555 | 1,666,650 |
| MALEK DAVID I | 30.00 | - | 4,166 | 124,980 |
| MURDOCH TRAVIS | 30.00 | - | 83,333 | 2,499,990 |
| ORBIMED ADVISORS LLC | 30.00 | - | 11,072,420 | 332,172,600 |
| RICKEY JAMES PAUL | 30.00 | - | 27,777 | 833,310 |
| VIEHBACHER CHRISTOPHER | 30.00 | - | 83,333 | 2,499,990 |
| 累积净数量 | 60,775,913 | |||
| 累积净值 ($) | 1,823,277,390 | |||
| 累积平均购买 ($) | 30.00 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| LUBNER DAVID CHARLES | 董事 | 07 Aug 2026 | 买 (+) | 55,555 | 30.00 | 1,666,650 |
| MURDOCH TRAVIS | 职员 | 07 Aug 2026 | 买 (+) | 83,333 | 30.00 | 2,499,990 |
| ANDERSON MICHELE A. | 职员 | 07 Aug 2026 | 买 (+) | 1,111 | 30.00 | 33,330 |
| VIEHBACHER CHRISTOPHER | 董事 | 07 Aug 2026 | 买 (+) | 83,333 | 30.00 | 2,499,990 |
| MALEK DAVID I | 董事 | 07 Aug 2026 | 买 (+) | 4,166 | 30.00 | 124,980 |
| RICKEY JAMES PAUL | 职员 | 07 Aug 2026 | 买 (+) | 27,777 | 30.00 | 833,310 |
| FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF U.A. | 07 Aug 2026 | 获得 (+) | 9,132,420 | 30.00 | 273,972,600 | |
| FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF U.A. | 07 Aug 2026 | 获得 (+) | 7,990,867 | 30.00 | 239,726,010 | |
| FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF U.A. | 07 Aug 2026 | 买 (+) | 1,920,000 | 30.00 | 57,600,000 | |
| FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF U.A. | 07 Aug 2026 | 买 (+) | 1,680,000 | 30.00 | 50,400,000 | |
| JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. | 07 Aug 2026 | 获得 (+) | 7,420,091 | 30.00 | 222,602,730 | |
| ORBIMED ADVISORS LLC | 董事 | 07 Aug 2026 | 获得 (+) | 9,132,420 | 30.00 | 273,972,600 |
| ORBIMED ADVISORS LLC | 董事 | 07 Aug 2026 | 买 (+) | 1,940,000 | 30.00 | 58,200,000 |
| CHIMOVITS EREZ | 董事 | 07 Aug 2026 | 获得 (+) | 9,132,420 | 30.00 | 273,972,600 |
| CHIMOVITS EREZ | 董事 | 07 Aug 2026 | 买 (+) | 1,940,000 | 30.00 | 58,200,000 |
| AH BIO FUND IV, L.P. | 07 Aug 2026 | 获得 (+) | 9,132,420 | 30.00 | 273,972,600 | |
| AH BIO FUND IV, L.P. | 07 Aug 2026 | 买 (+) | 1,100,000 | 30.00 | 33,000,000 | |
| 显示更多 | ||||||
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合